Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids

 

Show simple item record

dc.contributor.author Arens, James
dc.contributor.author Barnes, Karen
dc.contributor.author Crowley, Nicola
dc.contributor.author Maartens, Gary
dc.date.accessioned 2017-07-14T09:10:21Z
dc.date.available 2017-07-14T09:10:21Z
dc.date.issued 2007
dc.identifier.citation Arens, J., Barnes, K., Crowley, N., & Maartens, G. (2008). Treating AIDS-associated cerebral toxoplasmosis–pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. South African Medical Journal, 97(10), 956-958.
dc.identifier.uri http://hdl.handle.net/11427/24738
dc.description.abstract We conducted a retrospective study of AIDS-associated cerebral toxoplasmosis. Eighteen patients received pyrimethamine plus sulfadiazine and 25 co-trimoxazole, with comparable baseline characteristics. There were no differences in clinical outcomes, but co-trimoxazole was better tolerated (p = 0.066). There was also a trend towards more deaths among patients who received glucocorticoids.
dc.language.iso eng
dc.source South African Medical Journal
dc.source.uri http://www.samj.org.za/index.php/samj
dc.title Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids
dc.type Journal Article en_ZA
dc.date.updated 2016-01-12T09:36:08Z
uct.type.publication Research en_ZA
uct.type.resource Article en_ZA
dc.publisher.institution University of Cape Town
dc.publisher.faculty Faculty of Health Sciences en_ZA
dc.publisher.department Department of Medicine en_ZA
uct.type.filetype Text
uct.type.filetype Image
dc.identifier.apacitation Arens, J., Barnes, K., Crowley, N., & Maartens, G. (2007). Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. <i>South African Medical Journal</i>, http://hdl.handle.net/11427/24738 en_ZA
dc.identifier.chicagocitation Arens, James, Karen Barnes, Nicola Crowley, and Gary Maartens "Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids." <i>South African Medical Journal</i> (2007) http://hdl.handle.net/11427/24738 en_ZA
dc.identifier.vancouvercitation Arens J, Barnes K, Crowley N, Maartens G. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. South African Medical Journal. 2007; http://hdl.handle.net/11427/24738. en_ZA
dc.identifier.ris TY - Journal Article AU - Arens, James AU - Barnes, Karen AU - Crowley, Nicola AU - Maartens, Gary AB - We conducted a retrospective study of AIDS-associated cerebral toxoplasmosis. Eighteen patients received pyrimethamine plus sulfadiazine and 25 co-trimoxazole, with comparable baseline characteristics. There were no differences in clinical outcomes, but co-trimoxazole was better tolerated (p = 0.066). There was also a trend towards more deaths among patients who received glucocorticoids. DA - 2007 DB - OpenUCT DP - University of Cape Town J1 - South African Medical Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2007 T1 - Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids TI - Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids UR - http://hdl.handle.net/11427/24738 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record